Archive for the ‘Articles’ Category
Medical Patent Opportunities in Knee Joint Protection
According to Claudia Wallis, knee replacements surgeries will increase by 525% by 2030 (CNN Health, March 6, 2008). As a U.S. Registered Patent Attorney, I recognize the opportunities this figure represents in the various ways the medical community could help people prevent need for the surgery or handle life afterwards as appropriate.
Medical Patent Opportunities in Bloodless Solutions
Medical patent opportunities for "bloodless solutions" have been actualized in a wide range of medical devices in technology. With patients increasingly concerned with the risks associated with transfusions, the trend appears to be growing.
Patent Pending Drug for Artherosclerosis
Merck & Co, Inc., in collaboration with Arena Pharmaceuticals, is taking a patent pending drug into Phase One of a clinical trial (PharmaLive, January 25, 2008). Merck’s second generation niacin receptor agonist is a combatant to artherosclerosis. Will the patented drug enter the market? ... Read More
Patent Revocation: A Significant Risk?
I posted the information below in a separate blog I run for people interested in non-medical patents. However, I thought it would be of use to this community as well. The question being discussed is how ‘at-risk’ patent holders are for having their patents revoked. And the short answer is…very little. . T... Read More
A Patent-Pending Patent Protector?
How are you imbuing authenticity within your product's concept? When an idea is innovative enough, being first is itself the strongest voice of authenticity.
